Details of this Paper

Research paper

Description

solution


Question

Question;?How effective are infection control;policies for preventing the transmission of Methicillin-resistant;Staphylococcus aureus (MRSA) in hospital settings versus nursing home settings??;15-16 pager;1. Title Page;2. Abstract Page + Ultramini Abstract;3. Introduction;4. Methods;5. Results;6. Discussion;7. Figures and;Tables;8. References;1. TITLE PAGE;Article Title: Provide a concise, informative title, with no unnecessary words;? Author Name;? Affiliation:Institution;? Author information: Complete name, address, telephone number;and e-mail address;? Mentor Name;? Article word count;(exclusive of abstract and;references) on the title page is required.;? Hypothesis:Add a;separate section with the;testable hypothesis;Your first line starts here.;2. ABSTRACT PAGE;The Abstract should be structured into four paragraphsnot exceeding 250 words total.;It must be written in complete sentences, using pasttense, active verbs;and third person. Abbreviations should be avoided. No literature should be cited in this section.;The abstract must include;your testable hypothesis and how you tested it.;Sections;a) Hypothesis;describe the hypothesis of the study;b) Methods: identify;the study design and statistical methods used;c) Results: describe;the outcome of the study and the statistical significance, if appropriate;d) Conclusions: state;the significance of the results;? Provide a word;count for the Abstract;? Keywords: Following;the abstract, provide 3 to 10;keywords for indexing purposes;Ultramini Abstract (at;the bottom of the Abstract Page): Maximum 50 words.;Provide 1 to 3 sentences of no more than 50 words total;containing the essence of the paper.;The next line starts here.;3. INTRODUCTION;The Introduction should provide a clear statement of the;problem, the relevant literature on;the subject, and the proposed approach or solution. The introduction must be;? Well referenced;? Begins with an;impactful statement;? Narrows to the;focus of the paper;Citations will be written in parenthesis in a consistent;format throughout the paper.;The next line starts here.;4. METHODS;Should contain enough information to;allow the study to be replicated;? Databases used;? Search Strategy;? Search Terms;? Inclusion /;exclusion criteria;? Other relevant;information;The next line starts here.;5. RESULTS;The results should be presented with clarity and;precision. Results should be;explained, but largely without referring to the literature. Discussion, speculation and detailed interpretation;of data should not be included in the Results.;? Results should be discussed in a manner that;synthesizes results of multiple studies;? Include an Evidence;Table as an Appendix to the paper;The next line starts here.;6. DISCUSSION;Authors should explain what the results mean and;how the results relate to the hypothesis presented as the basis of the study.;The discussion should interpret;the findingsand should include;? Explanation of the;findings;? Interpretation of;the Results;? Limitations;? Future directions;? Conclusion: State;the conclusions in a few sentences at;the end of the paper.;The next line starts here.;7. FIGURES AND TABLES;Examples;Figure 1.Write the figure?s title here.;(Note: Insert;Figure 1 here,please delete these lines before submitting this form.);Table 1. Write the table?s;title here.;(Note: Insert Table;1 here. Please, delete these lines before submitting this form.);The next line starts here.;8. REFERENCES;General;information- how to cite: (http://www.ncbi.nlm.nih.gov/books/NBK7256/);Authors' last names;and initials, title of article, journal name, date, volume number, and;inclusive pages (list all authors when six or fewer, > six, list six and add;et al);Example;? Tilleman T.R.;Richards W.G., Zellos L., Johnson B.E., Jaklitsch M.T., Mueller J., Yeap B.Y.;Mujoomdar A.A., Ducko C.T., Bueno R., Sugarbaker D.J. Extrapleural pneumonectomy followed by intracavitary;intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for;treatment of malignant pleural mesothelioma: a phase II prospective study.J;ThoracCardiovasc Surg. 2009 Aug,138(2):405-11. doi;10.1016/j.jtcvs.2009.02.046.;? Bruzik J.P.Splicing glue: a role for SR proteins in trans splicing?MicrobPathog.;1996 Sep,21(3):149-55.;The next line with the references starts here.;Effective Formatting;? Use upper- and;lowercase type: It is much easier to read than all capital letters;? Use a consistent;typeface and size (i.e. Times New Roman, 12 point);? Double space your;paper;?;Include page numbers;Manuscript Submission;All Preliminary Drafts and Final Papers must be submitted via Moodle (LMS) + via email to your;mentor.Learn moreabout author guidelines:http://www.plosone.org/static/guidelines;http://www.ijms.info/external/files/instructions_authors.pdf;Aguide to publishing in scholarly journals;-Elsevier;http://www.elsevier.com/journals/journal-of-thoracic-and-cardiovascular-surgery/0022-5223/guide-for-authors;ABSTRACT PAGE;The Abstract should be structured into four paragraphs not exceeding 250 words total. It must be written in complete sentences, using past tense,active verbs, and third person. Abbreviations should be avoided. No literature should be cited in this section.;The abstract must include your testable hypothesis;and how you tested it.;Sections;Hypothesis: describe the hypothesis of the study;Methods: identify the study design and statistical methods used;Results: describe the outcome of the study and the statistical;significance, if appropriate;Conclusions: state the significance of the results;Provide a word count for the Abstract;Keywords: Following the abstract;provide 3 to 10 keywords for indexing purposes;Ultramini Abstract (at;the bottom of the Abstract Page);Maximum 50 words.;Provide 1 to 3 sentences of no more than 50 words total;containing the essence of the paper.;The next line starts here.;INTRODUCTION;The Introduction should provide;a clear statement of the problem, the relevant literature on the subject, and the;proposed approach or solution. The introduction must be;Well referenced;Begins with an impactful statement;Narrows to the focus of the paper;Citations will be written in parenthesis in a consistent format throughout;the paper.;The next line starts here.;METHODS;Should contain;enough information to allow the study to be replicated;Databases used;Search Strategy;Search Terms;Inclusion / exclusion criteria;Other relevant information;The next line starts here.;RESULTS;The results should be;presented with clarity and precision. Results should be explained, but largely without referring to the literature. Discussion, speculation and;detailed interpretation of data should not be included in the Results.;Results should be;discussed in a manner that synthesizes results of multiple studies;Include an Evidence Table as an Appendix to the paper;The next line starts here.;DISCUSSION;Authors should explain;what the results mean and how the results relate to the hypothesis presented as;the basis of the study.;The discussion should interpret;the findings and should include;Explanation of the findings;Interpretation of the Results;Limitations;Future directions;Conclusion: State the conclusions in a few sentences at the end of the paper.;The next line starts here.;FIGURES AND TABLES;Examples;Figure 1.Write the figure?s title here.;(Note: Insert Figure 1 here, please delete these lines before submitting;this form.);Table 1. Write the table?s title here.;(Note: Insert Table 1 here. Please, delete these lines before submitting;this form.);The next line starts here.;REFERENCES;General information- how to cite: (http://www.ncbi.nlm.nih.gov/books/NBK7256 /);Authors' last names and initials, title of article, journal name, date;volume number, and inclusive pages (list all authors when six or fewer, >;six, list six and add et al);Example;Tilleman T.R., Richards W.G., Zellos L., Johnson B.E., Jaklitsch M.T., Mueller;J., Yeap B.Y., Mujoomdar A.A., Ducko C.T., Bueno R., Sugarbaker D.J.;Extrapleural pneumonectomy followed by intracavitary intraoperative;hyperthermic cisplatin with pharmacologic cytoprotection for treatment of;malignant pleural mesothelioma: a phase II prospective study. J Thorac;Cardiovasc Surg. 2009 Aug,138(2):405-11. doi: 10.1016/j.jtcvs.2009.02.046.;Bruzik J.P. Splicing glue: a role for SR proteins in trans splicing?;Microb Pathog. 1996 Sep,21(3):149-55.;The next line with the references starts here.;Effective Formatting;? Use upper- and lowercase type: It is much easier to read than all;capital letters;? Use a consistent typeface and size (i.e. Times New Roman, 12 point);? Double space your paper

 

Paper#58630 | Written in 18-Jul-2015

Price : $47
SiteLock